Javascript Disabled Detected

You currently have javascript disabled. Several functions may not work. Please re-enable javascript to access full functionality.

Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Started by survenant , Jul 26 2016 11:03 AM

Pioglitazone

Please log in to reply

No replies to this topic

#1 survenant

Advanced Member

Members
98 posts

Posted 26 July 2016 - 11:03 AM

New clinical trial at Emory University (Georgia,US) . Pioglitazone hydrochloride is a drug approved by the Food and Drug Administration to treat diabetes and has been shown in laboratory studies to increase CML stem cell death when given together with TKI therapy

See Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Back to top

Back to Chronic Myeloid Leukemia

Also tagged with one or more of these keywords: Pioglitazone

	The Leukemia & Lymphoma Society Community → LLS Blood Cancer Discussion Boards → Chronic Myeloid Leukemia → Adding Pioglitazone to Imatinib May Improve Response Rate in CML Started by survenant , 06 Jan 2017 Pioglitazone, Imatinib		15 replies 563 views	r06ue1 25 Jan 2017
	The Leukemia & Lymphoma Society Community → LLS Blood Cancer Discussion Boards → Chronic Myeloid Leukemia → Combination of pioglitazone with tyrosine kinase inhibitor Started by survenant , 13 Jan 2016 pioglitazone, tki, cml, leukemia		1 reply 238 views	survenant 13 Jan 2016

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users

Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

#1 survenant

Also tagged with one or more of these keywords: Pioglitazone

Adding Pioglitazone to Imatinib May Improve Response Rate in CML

Combination of pioglitazone with tyrosine kinase inhibitor

1 user(s) are reading this topic

Sign In